Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-20-043742

Options or other derivatives

  • Director acquired 26,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Flannelly Barry P · Director

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-07-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +18,000 18,000 D
2020-07-23 Grant or award : show line 2 in the form Stock Option (Right to Buy) +8,250 26,250 D
Loading xslF345X03/doc4.xml…